Based on the 15-minute chart of Target's stock, a KDJ Death Cross and Bearish Marubozu pattern emerged on September 10, 2025, at 10:45. This technical indicator suggests a shift in the momentum of the stock price towards a downward trend, with a potential for further decline in value. The sellers currently dominate the market, and the bearish momentum is expected to persist.
Based on the 15-minute chart of Target's stock, a significant shift in momentum was observed on September 10, 2025, at 10:45. The KDJ Death Cross and Bearish Marubozu pattern triggered a bearish signal, suggesting a potential downward trend in the stock price. This pattern, characterized by a long body with no shadows above or below, indicates strong selling pressure
Bank First's 15min chart shows KDJ Death Cross and ...[1].
The KDJ Death Cross occurs when the K line of the KDJ indicator crosses below the D line, signaling a potential shift in the stock's momentum towards the downside. This formation follows a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks, including ASGN and Cushing NextGen .
Technical analysis provides valuable insights into potential stock price movements, but it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts.
Positive Outlook: Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00
Trimas Corp Stock Price, News & Analysis[2]. Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00
Trimas Corp Stock Price, News & Analysis[2]. CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00
Trimas Corp Stock Price, News & Analysis[2]. Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating
Trimas Corp Stock Price, News & Analysis[2]. Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00
Trimas Corp Stock Price, News & Analysis[2]. Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside
Trimas Corp Stock Price, News & Analysis[2]. Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00
Trimas Corp Stock Price, News & Analysis[2]. Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00
Trimas Corp Stock Price, News & Analysis[2]. JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating
Trimas Corp Stock Price, News & Analysis[2]. Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen
Trimas Corp Stock Price, News & Analysis[2]. Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup
Trimas Corp Stock Price, News & Analysis[2]. MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating
Trimas Corp Stock Price, News & Analysis[2]. Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00
Trimas Corp Stock Price, News & Analysis[2]. Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00
Trimas Corp Stock Price, News & Analysis[2]. Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target
Trimas Corp Stock Price, News & Analysis[2]. Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target
Trimas Corp Stock Price, News & Analysis[2]. Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00
Trimas Corp Stock Price, News & Analysis[2]. Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00
Trimas Corp Stock Price, News & Analysis[2]. Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00
Trimas Corp Stock Price, News & Analysis[2]. Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target
Trimas Corp Stock Price, News & Analysis[2]. PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank
Trimas Corp Stock Price, News & Analysis[2]. Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00
Trimas Corp Stock Price, News & Analysis[2].
References:
Bank First's 15min chart shows KDJ Death Cross and ...[1] https://www.ainvest.com/news/bank-15min-chart-shows-kdj-death-cross-bearish-marubozu-signals-2509/
Trimas Corp Stock Price, News & Analysis[2] https://www.ainvest.com/news/bank-15min-chart-shows-kdj-death-cross-bearish-marubozu-2509-86/
https://www.ainvest.com/news/chart-industries-triggers-kdj-golden-cross-bullish-momentum-builds-marubozu-candle-2508-55/
Comments
No comments yet